CAS 923950-08-7

dulaglutide

Description:

Dulaglutide is a synthetic peptide and a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily used in the management of type 2 diabetes. It is characterized by its ability to enhance insulin secretion in response to elevated blood glucose levels, thereby aiding in glycemic control. The substance is administered via subcutaneous injection and has a prolonged half-life due to its resistance to enzymatic degradation, allowing for once-weekly dosing. Dulaglutide is composed of 44 amino acids and features a modified structure that includes a linker and a fatty acid moiety, which contributes to its pharmacokinetic properties. It is known to promote weight loss and has cardiovascular benefits, making it a valuable option in diabetes management. Common side effects may include gastrointestinal disturbances, such as nausea and diarrhea. As with any medication, it is essential for patients to discuss potential risks and benefits with their healthcare provider.

Formula: C₂₀H₁₇N₃O₃

Synonyms:

• N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-(2-furyl)-6-methylimidazo[1,2-a]pyridin-3-amine

Dulaglutide

CAS: 923950-08-7

Dulaglutide (LY2189265) is a GLP-1 receptor agonist for studying type 2 diabetes mellitus (T2DM).

Color and Shape: Solid

Ref: TM-T75718

H-HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG-OH

CAS: 923950-08-7

H-HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG-OH is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote Tool

Formula: C₁₄₉H₂₂₁N₃₇O₄₉

Molecular weight: 3,314.61 g/mol

Ref: 3D-PH00227

Dulaglutide - solution in PBS

CAS: 923950-08-7

Glucagon-like peptide 1 (GLP-1) receptor agonist

Purity: Min. 95%

Ref: 3D-BD165587